Welcome to the SOCRA Phoenix / Valley of the Sun Chapter page. The information for the latest chapter meeting is below. If you have any questions, please reach out to the Chapter Chairperson or the SOCRA office at office@socra.org.
Register here: https://www.eventbrite.com/e/addressing-challenges-with-fda-483s-and-warning-letters-in-clinical-trials-tickets-957445935567
Objectives: Join us for an informative session where we will discuss strategies to tackle FDA 483s and warning letters in the realm of clinical trials. The pharmaceutical and medical device industries are subject to stringent regulations enforced by the FDA. Receiving an FDA Form 483 or a Warning Letter can have significant repercussions, including delays in product approvals, financial losses, and damage to reputation. This webinar will provide a comprehensive overview of these regulatory challenges and offer practical strategies for addressing and preventing them.
We ask you to kindly cancel if you cannot make the meeting so that others may attend.
SoCRA CE, meeting materials & recording (if available) will be emailed after attendance has been taken and reconciled, within approximately 2 weeks.
We look forward to "seeing" you all there!